entertainment -WSS

entertainment

author：leisure time 2025-09-30 04:58:27 - browse：379

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： Supreme Court strikes down use of affirmative action
Next article： What to watch for from Zogenix and Amicus clinical trials

focus

entertainment

WSS

CDC Director Mandy Cohen on transparency, trust, and health

Biden warns of ‘dark winter’ during final presidental debate

Report: NIH

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Senate panel puts off hardest PBM reforms for another day

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

focus

entertainment

Sign up for D.C. Diagnosis

knowledge

Continuity nursing helped my family in our darkest PICU moments

Scientists successfully use ultrasound imaging to map brain activity

In age of alternative facts, a scholarly course on calling out crap

New Alzheimer's drugs heat up race for early detection blood tests

Heart attack and stroke risk calculators need revising

Will the FTC rein in IQVIA's health data empire?

In Memoriam: Notable people who died in 2023

UHS says company favors patients whose insurance pays more

Trump demands the U.S. pay no more for drugs than other countries … again

The battle over 'scope creep' and who gets to be called 'doctor'

hotspot

Will the FTC rein in IQVIA's health data empire?

Device maker Teleflex to acquire urology company for $600M

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

New Alzheimer's drugs heat up race for early detection blood tests

Will the FTC rein in IQVIA's health data empire?

Startling documents reveal new facets of Sacklers' opioid empire

focus

leisure time

entertainment

hotspot